{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/chilblains/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"08c8ac64-d612-5dfe-9926-2d0dfbc02f14","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 1a5a951d-bb72-4c70-9bfd-c7b802305d8d --><h2>How should I assess a person with suspected chilblains?</h2><!-- end field 1a5a951d-bb72-4c70-9bfd-c7b802305d8d -->","summary":"","htmlStringContent":"<!-- begin item d689aade-10f2-437b-b689-2573db31eb9f --><!-- begin field a6e813a1-10c1-44ef-97df-6a3dd404a361 --><p><strong>Take a history asking about:</strong></p><ul><li>Exposure to cold.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/chilblains/diagnosis/clinical-features/\">Symptoms</a> including onset, distribution and progression of lesions.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/chilblains/background-information/causes/\">Risk factors</a> such as family history.</li><li>Previous episodes of similar lesions and persistence of symptoms outside the cold season.</li><li>Associated symptoms — carry out a systems review asking about associated symptoms such as rashes, photosensitivity, arthralgia, arthritis, oral ulcers or weight loss to help identify potential underlying cause such as connective tissue or haematological disorders.</li></ul><p><strong>Examine the person:</strong></p><ul><li>Look for <a class=\"topic-reference internal-reference\" href=\"/topics/chilblains/diagnosis/clinical-features/\">clinical signs</a> of chilblains such as red-purple macular, papular or nodular lesions on acral skin.</li><li>Check peripheral pulses looking for signs of peripheral vascular disease.<ul><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/peripheral-arterial-disease/\">Peripheral arterial disease</a>.</li></ul></li><li>Look for signs of diabetes — check sensation in the affected extremity to exclude neuropathy.<ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> and <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a>.</li></ul></li><li>Carry out a general examination looking for signs of associated underlying conditions such as lupus erythematosus.</li></ul><p><strong>Consider the need for investigations:</strong></p><ul><li>Investigations are not usually required unless an underlying cause is suspected or there is no history of cold exposure.<ul><li>If symptoms are severe (for example, if ulceration, necrosis or other significant skin changes are present) or persistent consider investigating for associated underlying conditions such as haematological malignancy, connective tissue disorders or cryoglobinaemia.</li></ul></li><li>If the diagnosis is in doubt discuss with/refer to dermatology.</li></ul><!-- end field a6e813a1-10c1-44ef-97df-6a3dd404a361 --><!-- end item d689aade-10f2-437b-b689-2573db31eb9f -->","topic":{"id":"98f988ea-4ee8-52e9-8212-438a79499f92","topicId":"17adddaf-c9b6-4278-9b49-932d14f56439","topicName":"Chilblains","slug":"chilblains","lastRevised":"Last revised in June 2018","chapters":[{"id":"541e07aa-8e84-55e1-817f-8d101eeb46fd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e6b34a51-a690-5858-9a53-0dc5d5b0e608","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"5f3bae74-0385-5bf1-b250-9e74f16cfe18","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"4ae9419d-bc20-56ba-91a1-0420a339c087","slug":"changes","fullItemName":"Changes"},{"id":"e57dda70-8cbd-58d2-a2fb-8901c08e6853","slug":"update","fullItemName":"Update"}]},{"id":"ddec423e-57a6-54df-ba06-4014b41b839c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"9315120c-762a-5273-867b-759b5537e4b8","slug":"goals","fullItemName":"Goals"},{"id":"666bca6f-0132-53bc-95cc-27fcbd0b4a96","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8b7e8a8e-c9dd-5555-8409-dfea005ea395","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"fa795717-6d81-577e-b792-90e487b3895c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"bff6f393-7347-51fa-8d46-95b80a272b9e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7da4aff5-e153-5f3f-bc51-0a943110c08d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"1cc6d520-d1d7-5bcd-9d7c-b1352c82d453","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"bba6260f-6b68-52b5-88c0-17f3ba449705","slug":"definition","fullItemName":"Definition"},{"id":"f4b6f42f-60f1-56db-9cc2-c9d377ec6c5a","slug":"causes","fullItemName":"Causes"},{"id":"adb617b9-5304-53c4-8f1f-6aaec8a9c35b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"16008222-9ac8-5d8e-9380-55d21f8ca4d9","slug":"complications","fullItemName":"Complications"},{"id":"16a3612e-723d-580a-a4c7-157274078ba8","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4c9a7bb6-deca-5726-8c77-5c4cc1bfa2a1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"468b6d0a-7e5f-59c0-affa-b0ee0c6eec91","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"08c8ac64-d612-5dfe-9926-2d0dfbc02f14","slug":"assessment","fullItemName":"Assessment"},{"id":"3db0f33f-97a0-5db2-83b8-ca9bb0e25bdc","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"ae9e38d9-23ba-50f8-8fd8-949711f14be6","fullItemName":"Management","slug":"management","subChapters":[{"id":"757e5e29-3beb-57b4-b55c-3050dd84bdc8","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"7f12498b-880e-5fca-908a-0c9547ba0d60","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b6be7c9c-cf67-5a2d-abb4-b8edc8d404e9","slug":"nifedipine","fullItemName":"Nifedipine"}]},{"id":"c98234ab-a54f-5b11-bd3d-ddc791a382d6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1c4fbb70-40dc-5931-9e8e-6d8fdcd80db4","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a6193060-7713-5e53-9336-66e3cb961a3a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c1d12d25-39b2-5827-a25e-dcf5536bf470","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"435de6c9-1336-5c37-8c94-8ab2ee7f2adb","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"cc4fe9b8-3554-5630-88cd-6dfee9d06235","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2d1b809a-3a66-5daa-a184-7cdfb748fe77","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d01450d0-bab3-5fff-9ec6-40623a484024","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4c9a7bb6-deca-5726-8c77-5c4cc1bfa2a1","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"3fc814e9-8ab2-5a7f-bdea-76157ed73ff8","slug":"basis-for-recommendation-f85","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field d9c9712a-692a-4593-8a0f-0961edc87424 --><h3>Basis for recommendation</h3><!-- end field d9c9712a-692a-4593-8a0f-0961edc87424 -->","summary":null,"htmlStringContent":"<!-- begin item f8547247-75ee-4406-bf2b-13f84a26858b --><!-- begin field 4dd83912-c812-4dd2-a4df-4e8b70bfcba6 --><p>The recommendations on how to assess a person with suspected chilblains are based on the clinical guideline <em>Perniosis (syn. Chilblains)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">PCDS, 2015</a>] and expert opinion in Rook’s textbook of dermatology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Bashir, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Guadagni, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Souwer, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Cappel, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Gordon, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Dane, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Souwer, 2017</a>].</p><h4>Systems review</h4><ul><li>Expert opinion in a clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">PCDS, 2015</a>], textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Bashir, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Guadagni, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Cappel, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Gordon, 2014</a>] agrees that chilblains can be associated with serious underlying conditions — a thorough systems review and examination is required to appropriately direct further assessment and management.</li></ul><h4>Investigations</h4><ul><li>Expert opinion in a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Bashir, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Cappel, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/chilblains/references/\">Dane, 2015</a>] is that chilblains can be diagnosed clinically and further investigations are not required unless signs or symptoms suggestive of an underlying condition are present or there is doubt about the diagnosis.</li></ul><!-- end field 4dd83912-c812-4dd2-a4df-4e8b70bfcba6 --><!-- end item f8547247-75ee-4406-bf2b-13f84a26858b -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}